Skip to main content
Fig. 4 | Cancer Nanotechnology

Fig. 4

From: Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer

Fig. 4

Immune response of C57BL/6 mice injected with PBS, PEI/pDNA, or RALA/pDNA nanoparticles (10 µg pDNA at N:P10). Mice received one injection per week for 3 weeks. 48 h after each injection three mice were sacrificed and the serum was assayed for IgG (a), IgM (b), IL-1β (c), and IL-6 (d) content. Datapoints represent mean ± SEM; N = 3

Back to article page